Tech Transfer

Science as part of the value chain

VIB researchers don't just contribute to the progress of scientific knowledge. Our research leads to new and innovative insights into life processes, benefiting society as a whole. Our technology transfer team focuses on translating research results into diverse new products (candidate drugs or therapies) that can be used to help patients. VIB combines excellence in research with distinction in technology transfer. This economic added value generates extra revenue for VIB.

 

 

 

 

 

 

VIB’s patent portfolio counts over 200 active patent families.
 
​A total of 130 collaborative agreements were signed.
 
Growing employment in VIB startups.
​The Ghent biotech cluster has appropriate infrastructure for biotech companies.